Marco Londei

Marco Londei

Plus aucun poste en cours
70 ans
Health Technology
Consumer Services
Commercial Services

Profil

Marco Londei worked as the Head-Therapeutic Area Immunosciences at Bristol Myers Squibb Co. from 2012 to 2014.
Prior to that, he was the Global Head-Autoimmunity Translational Medicine at Novartis Corp.
from 2005 to 2008.
From 2014 to 2020, he served as the Chief Medical Officer at AnaptysBio, Inc. He was also a Professor at Imperial College London from 1999 to 2013 and a Professor & Head-Gastroenterology Unit at University College London from 2003 to 2007.
Additionally, he worked as a Translational Science Officer at Novartis Institute for Functional Genomics, Inc. from 2005 to 2012.
Dr. Londei earned a doctorate degree from Alma Mater Studiorum - Università di Bologna.

Anciens postes connus de Marco Londei

SociétésPosteFin
ANAPTYSBIO, INC. Directeur Technique/Scientifique/R&D 25/03/2020
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01/09/2014
Corporate Officer/Principal 01/07/2013
Corporate Officer/Principal 01/10/2012
Corporate Officer/Principal 01/08/2008
Voir l'expérience en détail de Marco Londei

Formation de Marco Londei

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

98

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

  1. Bourse
  2. Insiders
  3. Marco Londei
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT